BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18392332)

  • 1. Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.
    Wexberg P; Jordanova N; Strehblow C; Syeda B; Meyer B; Charvat S; Zorn G; Scheinig D; Wojta J; Huber K; Glogar D; Gyöngyösi M
    Thromb Haemost; 2008 Apr; 99(4):739-48. PubMed ID: 18392332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients.
    Szük T; Fejes Z; Debreceni IB; Kerényi A; Édes I; Kappelmayer J; Nagy B
    Platelets; 2016 Jul; 27(5):410-9. PubMed ID: 26765134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
    Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.
    Christ G; Nikfardjam M; Huber-Beckmann R; Gottsauner-Wolf M; Glogar D; Binder BR; Wojta J; Huber K
    J Thromb Haemost; 2005 Feb; 3(2):233-9. PubMed ID: 15670026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ; Qin XW; Yang XC; Li ZC; Zeng HS; Xu B; Gao Z; Wu YJ; Zhang X; Zhang CY
    Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
    Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of point stenting of extended coronary stenosis in patients with ischemic heart disease].
    Puretskiĭ MV; Abugov SA; Saakian IuM
    Vestn Rentgenol Radiol; 2002; (6):17-24. PubMed ID: 12722619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of the TAIS coronary stent implantation: nine month multicenter study].
    Samko AN; Belenkov IuN; Batyraliev TA; Pershukov IV; Niiazova-Karben ZA; Sercelik A; Calenici O; Karaus A; Guler N; Eryonucu B
    Ter Arkh; 2003; 75(8):12-7. PubMed ID: 14520843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation.
    Mizia-Stec K; Gasior Z; Haberka M; Mizia M; Chmiel A; Janowska J; Holecki M; Mielczarek M; Zahorska-Markiewicz B
    Kardiol Pol; 2009 Jan; 67(1):9-17; discussion 18. PubMed ID: 19253185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
    Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
    N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis.
    Lau HK; Segev A; Hegele RA; Sparkes JD; Teitel JM; Chisholm RJ; Strauss BH
    Thromb Haemost; 2003 Dec; 90(6):1187-91. PubMed ID: 14652655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
    L'Allier PL; Tardif JC; Grégoire J; Joyal M; Lespérance J; Fortier A; Guertin MC
    Can J Cardiol; 2005 May; 21(6):495-500. PubMed ID: 15917878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
    Katsaros KM; Kastl SP; Huber K; Zorn G; Maurer G; Glogar D; Wojta J; Christ G; Speidl WS
    Thromb Res; 2008; 123(1):79-84. PubMed ID: 18558425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortening the stent length reduces restenosis with bare metal stents: matched pair comparison of short stenting and conventional stenting.
    Dietz U; Holz N; Dauer C; Lambertz H
    Heart; 2006 Jan; 92(1):80-4. PubMed ID: 15883134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation.
    Hammwöhner M; Ittenson A; Dierkes J; Bukowska A; Klein HU; Lendeckel U; Goette A
    Exp Biol Med (Maywood); 2007 Apr; 232(4):581-9. PubMed ID: 17392495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.